Quick answers
- What is Rh-oligopeptide-1 used for?
- The Drug Facts label of Sandra Plasencia PDRN Rejuvenating Serum (Guangzhou Meijiao Medical Biotechnology Co., Ltd.) lists these uses: Dispense 1-2 pumps onto cleanfingertips. Gently apply to face and neck usingupward motions.Use morning and nightbefore moisturizer.
- Do I need a prescription for Rh-oligopeptide-1?
- No. The products on this page are sold without a prescription (over the counter).
- Is a store brand the same as the name brand?
- Products listed together below have the same active ingredient, in the same amount and the same form, as registered with the FDA. Inactive ingredients (such as colors, flavors and fillers) and package sizes can differ. Compare the “Active ingredient” box on both packages, and ask a pharmacist if you are not sure.
- Has Rh-oligopeptide-1 been recalled?
- No recall linked to these products appears in the FDA enforcement reports we use.
Drug Facts label
Every over-the-counter medicine must carry a “Drug Facts” box in the same order, set by FDA rules. Below is the label of one product for each common strength and form, quoted word for word. Your own package can differ (for example, children’s products have other directions): always follow the label on your package.
Sandra Plasencia PDRN Rejuvenating Serum · Guangzhou Meijiao Medical Biotechnology Co., Ltd.
RH-OLIGOPEPTIDE-1 1%, liquid (cutaneous)
Purpose
Rejuvenating and firming serum powered byTremella fuciformis extract, PDRN (SodiumDNA), multi-peptides including Oligopetide-1,Palmitoyl Tripeptide-5, and Hexapeptide-9, todeeply repair skin, boost elasticity, smooth finelines, and restore a youthful glow.
Uses
Dispense 1-2 pumps onto cleanfingertips. Gently apply to face and neck usingupward motions.Use morning and nightbefore moisturizer,
Warnings
CAUTION: For external use only. Avoid directcontact with eyes. If irritation occurs, stopuse and consult a doctor if needed.Patch test recommended. Do not useif you are allergic to any of the ingredients.
Keep out of reach of children
Use: Dispense 1-2 pumps onto cleanfingertips. Gently apply to face and neck usingupward motions.Use morning and nightbefore moisturizer,
Directions
Use: Dispense 1-2 pumps onto cleanfingertips. Gently apply to face and neck usingupward motions.Use morning and nightbefore moisturizer,
Inactive ingredients
INGREDIENIS : Tremella Fuciformis Extract, Water, Glycerin,Oligopeptide-1, Oligopeptide-3, PalmitoylTripeptide-5, Hexapeptide-9, Sodium DNA(PDRN),Macromolecular Hyaluronic Acid
— FDA label of Sandra Plasencia PDRN Rejuvenating Serum, Guangzhou Meijiao Medical Biotechnology Co., Ltd., effective November 27, 2025. See the official label on DailyMed →
This page is not medical advice. Read the label on your package, and ask a pharmacist or doctor if you are not sure a medicine is right for you, for your child, or with your other medicines.
Same medicine, other brands
Each group lists the products that have exactly the same active ingredient, in the same amount and form, as registered with the FDA (NDC Directory). A store brand in the same group has the same medicine as the name brand; inactive ingredients, flavors and package sizes can differ. Each product links to its own official label.
RH-OLIGOPEPTIDE-1 1% · liquid (cutaneous) · 2 products
Companies that sell this medicine
The company named on the package (maker or distributor), as listed in the FDA NDC Directory, with its number of over-the-counter products of this medicine.
- Odlumivie1 product
- Guangzhou Meijiao Medical Biotechnology Co., Ltd.1 product
Recalls
No recall linked to these products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- FDA rule for the Drug Facts label (21 CFR 201.66)
Only medicines marketed under FDA rules for nonprescription drugs (an FDA monograph or an FDA approval) are listed. Homeopathic products are not listed: the FDA does not evaluate them for safety or effectiveness.